Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer. - Wikidata - awgldk - TriplyDB

Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer.

Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer.

http://www.wikidata.org/entity/Q42480769

about

Segmentation precision of abdominal anatomy for MRI-based radiotherapy.Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract.An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy.Concurrent segmentation of the prostate on MRI and CT via linked statistical shape models for radiotherapy planning.Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case.Maintaining prostate contouring consistency following an educational intervention Uncertainties in target volume delineation in radiotherapy - are they relevant and what can we do about them?Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study.Magnetic resonance imaging in diagnosis, staging and radiotherapy planning for prostate cancer.Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer.Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.MRI scans significantly change target coverage decisions in radical radiotherapy for prostate cancer.Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study.A review of interventions to reduce inter-observer variability in volume delineation in radiation oncology.The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging.ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.Inter- and intra-observer variability in contouring of the prostate gland on planning computed tomography and cone beam computed tomography.What's new in target volume definition for radiologists in ICRU Report 71? How can the ICRU volume definitions be integrated in clinical practice?Investigation on the performance of dedicated radiotherapy positioning devices for MR scanning for prostate planning.Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.MRI Reduces Variation of Contouring for Boost Clinical Target Volume in Breast Cancer Patients Without Surgical Clips in the Tumour Bed.Compared planning dosimetry of TOMO, VMAT and IMRT in rectal cancer with different simulated positions.Quantitative evaluation of diffusion-weighted imaging techniques for the purposes of radiotherapy planning in the prostate.Variability in prostate and seminal vesicle delineations defined on magnetic resonance images, a multi-observer, -center and -sequence study Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?Improved tumour control probability with MRI-based prostate brachytherapy treatment planning.Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology.Delineation of the larynx as organ at risk in radiotherapy: a contouring course within "Rete Oncologica Piemonte-Valle d'Aosta" network to reduce inter- and intraobserver variability.Moderate hypofractionation for prostate cancer: A user's guide.Interobserver variation in target volume for salvage radiotherapy in recurrent prostate cancer patients after radical prostatectomy using CT versus combined CT and MRI: a multicenter study (KROG 13-11).Fully automatic deformable registration of pretreatment MRI/CT for image-guided prostate radiotherapy planning.Interobserver variability in gross tumor volume delineation for hepatocellular carcinoma : Results of Korean Radiation Oncology Group 1207 study.Quantitative assessment of biliary stent artifacts on MR images: Potential implications for target delineation in radiotherapy.Technical Note: Radiological properties of tissue surrogates used in a multimodality deformable pelvic phantom for MR-guided radiotherapy.Investigating the clinical aspects of using CT vs. CT-MRI images during organ delineation and treatment planning in prostate cancer radiotherapy.Automatic segmentation of the prostate in 3D MR images by atlas matching using localized mutual information.Planning magnetic resonance imaging for prostate cancer intensity-modulated radiation therapy: Impact on target volumes, radiotherapy dose and androgen deprivation administration.

P2860

Q34415537-F7C63C64-23B6-45F6-88D2-A41D20807C0F Q34578957-A00CBBA1-01A3-48FB-864E-5360B10986DF Q35285438-0F86CAA1-B6E3-49AC-8602-FA08B96EC0B9 Q35915553-A893B136-3862-4A2D-B625-FE31B1564192 Q37038061-9AEDA932-AB64-429C-910E-E68235ED4A97 Q37243120-54003B65-4E4B-4543-B96D-887FDC710D17 Q37258706-FFD710AB-8E58-4725-94F2-87BC46D77A68 Q37578562-F4EFDF8F-2A65-474C-9011-CEE9D49AB8BA Q37719606-B729C7F3-0EC5-4F96-9AFA-15259153C2AD Q37832487-C538E4BF-189F-4042-81B4-C9043A006FD8 Q37968978-F6D343C9-EA57-4836-AF5E-B24922F348F1 Q37979128-E0301CA1-3AB3-4BC7-92D3-1631BB50E099 Q38201176-4866AFB0-1B85-4843-9C78-79813CA82863 Q38633618-975DD862-9337-46FF-B5C8-22AD90B90B40 Q38832522-02775D36-1B50-48F2-8622-0DE0DACA4C2E Q38851017-ED068E90-DDA5-4809-8B3A-837F5816D385 Q39456200-1A586624-FAFA-4BC7-B9C5-12913DF15E5B Q39773584-E1C1F7FE-7E37-46D1-8A3C-9CF6396F4158 Q40200329-330523F3-852F-40BA-9CDD-6CCAE22ABBC1 Q40807493-65195185-F8B4-40FA-8326-47DFA6625B83 Q40934915-00762225-7CBE-43EB-B11D-BF4FAF5E9A6E Q41042401-81440FFE-3DDB-4372-90A0-40910EB5E954 Q41091862-FE989990-1FAD-4930-8190-F754E651529D Q41295871-B819FB09-7480-4486-B481-20F5F72EDD7B Q41971411-5C1AFAEE-FDA6-4525-A928-B1B03A02EA88 Q43287327-3AB910B0-784A-4D67-A5D3-A043CF5B4DFF Q43379694-657EAE78-128D-49BA-B4DF-6F4DA118EC6D Q44322324-27B7B8DE-ECE4-4E7C-B531-60BB794F22D5 Q45025743-D7F70E09-A73A-42CD-B033-E59AA4148EC7 Q46012032-0ABBC9B7-CD84-4D97-BCE1-E89719789FFD Q48157099-961484F4-3859-4D9B-A132-465EF789E74B Q48238146-D65E22BC-CB26-4A14-9483-023D28BAD793 Q50062202-A9A4C2A5-A8BB-4EEE-9019-1D337EA2F1AF Q50088072-19CBD60F-A970-49A3-8C64-391A95F2DFD0 Q50594386-AAEAFB83-8AAF-482A-9BC2-2A86B3E36E35 Q51122883-C8D604FF-F62E-40DE-8184-25C8148BC3E4 Q51536139-3884AFF5-CF07-4EB6-880F-C1E2AE05E358 Q51576010-0CD0EFC7-37AF-4072-A4E2-9BB4BB170D08 Q51878500-B5A79E44-E8F0-4ED3-A001-C209D407ACB0 Q52532655-6418BAF0-21BB-40BC-968A-722E90B3BF64

P2860

Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer.

http://www.wikidata.org/entity/Q42480769

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Interobserver delineation vari ...... iotherapy for prostate cancer.

@en

Interobserver delineation vari ...... iotherapy for prostate cancer.

@nl

type

label

Interobserver delineation vari ...... iotherapy for prostate cancer.

@en

Interobserver delineation vari ...... iotherapy for prostate cancer.

@nl

prefLabel

Interobserver delineation vari ...... iotherapy for prostate cancer.

@en

Interobserver delineation vari ...... iotherapy for prostate cancer.

@nl

P1433

Q42480769-89EEA049-8B55-49DE-B5A6-D776C7D60D46

P1476

Q42480769-DD081119-A136-469E-ADC7-AE456914632C

P2093

Q42480769-1149E6B6-3589-479E-8762-D6AC78052616

Q42480769-4241A5DF-51A7-463E-BBAC-F25E29C6FF39

Q42480769-568CA6B4-26F5-4F08-9D81-7C49E89D38A7

Q42480769-87F7807D-6BAB-4E41-B34C-2C82C4AA842B

Q42480769-B08D3A8D-F5A1-4B5C-881D-54DC6BE17055

Q42480769-D1AE7C3A-83A3-47B5-99E9-BA5F89F5D027

Q42480769-D67637D6-B9A2-45BF-97D1-45E40952AFA4

Q42480769-FA0C86BC-5910-4746-A1A9-38F90FB1D5EC

P2888

Q42480769-53D05CD6-3662-4F95-88B8-FFCC69720A66

P304

Q42480769-ED060D2F-6FD2-474E-9325-BE367468462B

P31

Q42480769-D55BAA79-552F-43C5-BB83-9D9D8FE06CC2

P356

Q42480769-245EF416-5FA4-4926-BABC-DEB1DE71AB08

P433

Q42480769-7D4F178F-0A67-45EA-8DEC-24F0762A082A

P478

Q42480769-3CFBEFDF-C789-405E-9C31-68975E0FA870

P577

Q42480769-BBE864C3-0393-49D4-A2A2-F2DD6941DC11

P698

Q42480769-EA815EC2-74D3-4A85-AAFE-EC036B185011

P921

Q42480769-4E139C2A-7CD6-40A9-95B6-9DAD408FBF5C

P356

S00066-005-1383-X

P1433

Strahlentherapie und Onkologie

P1476

Interobserver delineation vari ...... iotherapy for prostate cancer.

@en

P2093

Filip Claus

http://www.w3.org/2001/XMLSchema#string

Geert M Villeirs

http://www.w3.org/2001/XMLSchema#string

Gert O De Meerleer

http://www.w3.org/2001/XMLSchema#string

Koen Van Vaerenbergh

http://www.w3.org/2001/XMLSchema#string

Koenraad L Verstraete

http://www.w3.org/2001/XMLSchema#string

Luc Vakaet

http://www.w3.org/2001/XMLSchema#string

Samuel Bral

http://www.w3.org/2001/XMLSchema#string

Wilfried J De Neve

http://www.w3.org/2001/XMLSchema#string

P2888

s00066-005-1383-x

P304

424-430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00066-005-1383-X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15995835

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy